z-logo
open-access-imgOpen Access
Safety and Efficacy of Sertraline for Depression in Patients with CHF (SADHART-CHF): A randomized, double-blind, placebo-controlled trial of sertraline for major depression with congestive heart failure
Author(s) -
Wei Jiang,
Christopher M. O’Connor,
Susan G. Silva,
Maragatha Kuchibhatla,
Michael S. Cuffe,
Dwayne D. Callwood,
Bosh Zakhary,
Elizabeth Henke,
Rebekka M. Arias,
Ranga Krishnan
Publication year - 2008
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/j12r-y609
Subject(s) - sertraline , depression (economics) , heart failure , placebo , medicine , randomized controlled trial , double blind , placebo controlled study , cardiology , antidepressant , alternative medicine , pathology , hippocampus , economics , macroeconomics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom